The small molecule TGF-β R1 inhibitors SB431542 and GW788388 have been shown to reduce TGF-β-mediated signaling and tissue fibrosis in mouse models of kidney, liver and lung fibrosis [57–60]. The gene discussed is TGFB1; the disease is pulmonary fibrosis.